1.

In Aug 2020, the Drug Controller General of India’s office has approved whose application for phase II and III clinical trials of the University of Oxford’s COVID-19 vaccine candidate Covishield?

A. Panacea Biotec
B. Shantha Biotechnics
C. Biocon
D. Serum Institute of India
E. Sun Pharma
Answer» E. Sun Pharma


Discussion

No Comment Found